Detalhe da pesquisa
1.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Lancet Oncol
; 16(3): 257-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25704439
2.
Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices.
J Manag Care Pharm
; 13(4): 337-48, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17506600
3.
A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer.
J Cancer
; 8(10): 1872-1883, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819385
4.
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.
Target Oncol
; 11(3): 317-27, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26507836
5.
Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.
J Clin Oncol
; 29(33): 4394-400, 2011 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969495
6.
Chemokine expression in tumor-to-tumor metastasis.
Oncol Lett
; 1(3): 449-452, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22966324